Apyx Medical Corporation (APYX) |
| 4.69 0.04 (0.86%) 06-12 16:00 |
| Open: | 4.66 |
| High: | 4.99 |
| Low: | 4.63 |
| Volume: | 160,919 |
| Market Cap: | 196(M) |
| PE Ratio: | -21.32 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 5.93 |
| Resistance 1: | 5.08 |
| Pivot price: | 4.28 |
| Support 1: | 4.04 |
| Support 2: | 3.40 |
| 52w High: | 5.08 |
| 52w Low: | 1.59 |
Apyx Medical Corporation, an energy technology firm established in 1982 and headquartered in Clearwater, Florida, focuses on the development, manufacturing, and global sale of medical devices for both the aesthetic and surgical fields. The company operates through two main divisions: Advanced Energy and Original Equipment Manufacturing (OEM). Among its key innovations is the Helium Plasma Generator, which delivers a controlled combination of RF energy and helium to precisely cut, coagulate, and ablate soft tissue in open and laparoscopic surgical procedures. For the cosmetic surgery market, Apyx Medical offers its Renuvion product line, enabling plastic surgeons and other aesthetic practitioners to apply targeted heat for desired patient outcomes. Concurrently, the J-Plasma brand caters specifically to the hospital surgical sector. Furthermore, the company designs, produces, and sells disposable hand pieces, alongside OEM generators and their related accessories. The entity was previously known as Bovie Medical Corporation, changing its name to Apyx Medical Corporation in January 2019.
| EPS | -0.220 |
| Book Value | 0.310 |
| PEG Ratio | 0.59 |
| Gross Profit | 0.843 |
| Profit Margin (%) | -16.40 |
| Operating Margin (%) | -7.29 |
| Return on Assets (ttm) | -4.4 |
| Return on Equity (ttm) | -76.5 |
Wed, 27 May 2026
Real Renuvion patients hit the runway in Apyx’s Miami Swim Week show - Stock Titan
Wed, 27 May 2026
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway - PR Newswire
Thu, 21 May 2026
New Apyx Medical (APYX) data backs Avéli and Renuvion cellulite treatment - Stock Titan
Thu, 14 May 2026
Apyx Medical Corporation Announces Retrospective Clinical - GlobeNewswire
Mon, 11 May 2026
Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50 - Yahoo Finance
Mon, 11 May 2026
[8-K] Apyx Medical Corp Reports Material Event - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |